Circular suture of the uterine serosa and myometrium layer around placental attachment site for refractory postpartum hemorrhage
- PMID: 33590569
- DOI: 10.1111/jog.14695
Circular suture of the uterine serosa and myometrium layer around placental attachment site for refractory postpartum hemorrhage
Abstract
Objective: The aim of the study was to analyze the clinical outcomes of circular suture at placental attachment site for refractory postpartum hemorrhage (PPH), which could block blood supply of the serosa and myometrium layer.
Methods: Eighty cases of refractory PPH were enrolled and retrospective analyzed in this study for further analysis from a consecutive single center database between 2010 and 2018. After undergoing circular suture of the uterine serosa and myometrium layer around placental attachment site, surgical and perioperative outcomes were recorded and analyzed.
Results: Among all the patients enrolled, 28 cases (35.0%) of refractory PPH were mainly caused by uterine inertia, 36 cases (45.0%) caused by ectopic placenta, and 2 cases (2.5%) caused by coagulation disorders. After circular suture of the uterine serosa and myometrium layer at placental attachment site, all the uterine active bleeding was controlled below 40 ml without recurrence. The perioperative results were similar between the vaginal and cesarean sections groups.
Conclusions: Circular suture of the uterine serosa and myometrium at the placental attachment site could control refractory PPH with few postoperative complications. Circular suture around placenta site could be applied in time to protect the endometrium even in primary hospital.
Keywords: circular suture; placental attachment site; refractory postpartum hemorrhage; retrospective study; surgical treatment.
© 2021 Japan Society of Obstetrics and Gynecology.
Comment in
-
Letter to "Circular suture of the uterine serosa and myometrium layer around placental attachment site for refractory postpartum hemorrhage": For uterine inertia and DIC?J Obstet Gynaecol Res. 2021 Nov;47(11):4131-4133. doi: 10.1111/jog.14994. Epub 2021 Sep 23. J Obstet Gynaecol Res. 2021. PMID: 34558149 No abstract available.
References
-
- Anger HA, Dabash R, Durocher J, Hassanein N, Ononge S, Frye LJ, et al. The effectiveness and safety of introducing condom-catheter uterine balloon tamponade for postpartum haemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped wedge, cluster-randomised trial. BJOG. 2019;126:1612-21.
-
- Arulkumaran S, Fuchtner C. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis-commentary. Am J Obstet Gynecol. 2020;222:291-2.
-
- Adnan N, Conlan-Trant R, McCormick C, Boland F, Murphy DJ. Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial. BMJ. 2018;362:k3546.
-
- Burke TF, Ahn R, Nelson BD, Hines R, Kamara J, Oguttu M, et al. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multi-Centre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG. 2016;123:1532-40.
-
- Klumpner TT, Kountanis JA, Meyer SR, Ortwine J, Bauer ME, Carver A, et al. Use of a novel electronic maternal surveillance system and the maternal early warning criteria to detect severe postpartum hemorrhage. Anesth Analg. 2020;131:857-65.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
